Latest Leadership Changes News

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

Nick Scali Limited reported a robust $62 million underlying profit for FY25, completed its UK acquisition equity raise, and announced key leadership changes as it eyes accelerated growth in FY26.

L1 Group has appointed Julian Russell as its new CEO and Managing Director, marking a strategic leadership transition aimed at capitalising on growth opportunities. Russell’s proven track record in financial services turnaround sets the stage for renewed momentum.

Jeff Peters has stepped down as CEO and Managing Director of L1 Group following the successful merger with L1 Capital, marking a key leadership transition for the company.

Boss Energy reports a record quarterly uranium production at its Honeymoon Project, with costs coming in below FY26 guidance and a robust cash position. The company also announces a leadership change as Matthew Dusci takes the helm as CEO.

Jatcorp’s Q1 FY26 revenue dipped 8% following a record Q4, yet the company advanced key growth initiatives including Southeast Asia expansion and a leadership change.

dorsaVi reports breakthrough RRAM sensor performance and secures a major US physical therapy deal, backed by a $5 million capital raise and new leadership appointments.

Lincoln Minerals has identified promising new drill targets at its Minbrie Copper-Base Metals Project in South Australia and secured $2.25 million in funding to advance exploration activities.

Buxton Resources reports promising assay results from its maiden drilling at the Centurion Project, alongside strategic leadership changes and a solid cash position heading into 2026.

CSL Limited has revised its financial outlook for FY26, citing lower US influenza vaccination rates and government cost controls in China, while postponing the planned demerger of its Seqirus vaccine business and announcing a major cost-saving program.

XPON Technologies reports a robust Q1 FY26 with 17.5% revenue growth, positive cash flow, and strategic leadership changes, setting a strong foundation for the year ahead.

Lark Distilling Co. reported a 10% increase in net sales for Q1 FY26, driven by strong domestic and Asian export growth, while preparing for a major brand restage and leadership change.